(Philadelphia,
PA) Depressed adolescents who are highly receptive to
tobacco advertising are most vulnerable to experiment
with smoking, a study by researchers from the University
of Pennsylvania School of Medicine and Georgetown
University indicates. This finding, published in the
March issue of the Journal of Pediatric Psychology,
leads researchers to believe that tailoring prevention
and intervention efforts to encompass tobacco advertising's
effects and the role of depression could lead to a reduction
in youth smoking.
Approximately 36 percent of all US adolescents are current
smokers. The Centers for Disease Control and Prevention
estimates that five million of today's adolescents will
die prematurely from smoking-related illnesses, creating
approximately $200 billion in future health care costs.
Why so many adolescents start and continue to smoke
despite the associated health risks remains an important
public health question. Previous research has shown
that the nicotine contained in cigarettes is a psychostimulant
and can ameliorate depressive symptoms by inducing feelings
of euphoria and relaxation.
Senior author Janet Audrain, PhD, from the University
of Pennsylvania Cancer Center and Department
of Psychiatry, and researchers from Georgetown University
are exploring the social, psychological and genetic
factors that influence adolescents' decisions about
smoking. Audrain's group surveyed over 1,100 ninth grade
students. These students completed a survey that assessed
current smoking practices, exposure to other smokers,
levels of depression, and receptivity to tobacco advertising.
Demographic data including age, gender, and race/ethnicity
were also collected.
Sixty percent of the students reported
that they were never smokers, i.e., "never tried
or experimented with smoking, even a few puffs."
Forty percent reported ever being smokers, i.e., "ever
smoked at least a partial or whole cigarette."
The data show that adolescents who are exposed to peer
smoking are more likely to smoke themselves. Furthermore,
adolescents who are highly receptive to tobacco advertising
and have clinically significant symptoms of depression
are also more likely to smoke than adolescents without
these symptoms.
"It is critically important that adolescents, particularly
those who grow up in households where one or more smokers
are present, receive messages early in life about the
hazards associated with smoking," said Kenneth
P. Tercyak, PhD, study co-investigator and author. In
tailoring these messages to adolescents, it is also
important to consider their current psychological state.
The researchers suggest that anti-tobacco advertising
campaigns designed to dispel myths about the benefits
of smoking as portrayed in tobacco advertisements (i.e.
ads that insinuate the smoking can be a key to happiness
and social success) should incorporate messages about
the possible relationship between depression and smoking.
According to Audrain, such campaigns should also include
messages about "how tobacco companies may be exploiting
those who are psychologically vulnerable to smoke."
This research was funded by the National Cancer Institute
and the National Institute on Drug Abuse and was conducted
by the University of Pennsylvania/Georgetown University
Transdisciplinary Tobacco Use Research Center.
# # #
The University of Pennsylvania Health System is
distinguished not only by its historical significance
- first hospital (1751), first medical school (1765),
first university teaching hospital (1874), first fully
integrated academic health system (1993) - but by its
position as a major player on the world stage of medicine
in the 21st century. Committed to a three-part mission
of education, research, and clinical excellence, UPHS
has excelled in all three areas. Penn ranked second
among all American medical schools that received funs
from the National Institutes of Health, perhaps the
single most important barometer of research strength.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.